Nexthera Capital »

Biohaven Pharmaceutical Holding shares owned by Nexthera Capital

Quarter-by-quarter ownership of Biohaven Pharmaceutical Holding shares owned by Nexthera Capital from 13F filings

Historical chart of Nexthera Capital investment in Biohaven Pharmaceutical Holding

Tip: Access up to 7 years of quarterly data

All positions including Biohaven Pharmaceutical Holding held by Nexthera Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven Pharmaceutical Holding by Nexthera Capital

Quarter filed Position value Share count Share price at filing
2019-06-30 $3.8M 86k 43.79

More positions owned by Nexthera Capital

Intercept Pharmaceuticals In
Insmed (INSM)
Audentes Therapeutics
Neurocrine Biosciences (NBIX)
Sarepta Therapeutics (SRPT)
Global Blood Therapeutics In
Immunomedics
Coherus Biosciences (CHRS)
Ascendis Pharma A S (ASND)
Pacira Pharmaceuticals (PCRX)
Urogen Pharma (URGN)
Uniqure Nv (QURE)
Amarin Corporation (AMRN)
Abbvie (ABBV)
Biohaven Pharmaceutical Holding

View all positions for Nexthera Capital

Top funds holding Biohaven Pharmaceutical Holding

Knoll Capital Management
Birchview Capital
Brevan Howard Capital Management

View all funds holding Biohaven Pharmaceutical Holding